Seres Therapeutics, Inc. (MCRB) Form 8-K Material Events

Seres Therapeutics, Inc. (MCRB) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.

Ticker: MCRB CIK: 1609809 Exchange: Nasdaq SIC 2834: Pharmaceutical Preparations Fiscal Year End: 12/31 State: DE

Independent PCAOB Auditor

Explore PCAOB Audit Intelligence →
Audit Firm PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerHolly Reeves
Audit LocationBoston, Massachusetts, United States

Latest SEC EDGAR Filings

Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions
Form Filing Date Reporting Period Description Accession Number Actions
EFFECT 2026-08-21 — EFFECT Filing 9999999995-26-002733 View SEC Doc Filr Page
4 2026-08-18 2026-08-15 4 0001193125-26-355734 View SEC Doc Filr Page
4 2026-08-18 2026-08-15 4 0001193125-26-355722 View SEC Doc Filr Page
4 2026-08-18 2026-08-15 4 0001193125-26-355718 View SEC Doc Filr Page
4 2026-08-18 2026-08-15 4 0001193125-26-355712 View SEC Doc Filr Page
S-3 2026-08-13 — S-3 0001193125-26-349330 View SEC Doc Filr Page
10-Q 2026-08-05 2026-06-30 10-Q 0001193125-26-334174 View SEC Doc Filr Page
8-K 2026-08-05 2026-08-05 8-K 0001193125-26-333820 View SEC Doc Filr Page
8-K 2026-08-04 2026-07-31 8-K 0001193125-26-332742 View SEC Doc Filr Page
424B5 2026-08-04 — 424B5 0001193125-26-332730 View SEC Doc Filr Page
4 2026-07-10 2026-07-08 4 0001193125-26-300927 View SEC Doc Filr Page
4 2026-07-10 2026-07-08 4 0001193125-26-300925 View SEC Doc Filr Page
4 2026-07-10 2026-07-08 4 0001193125-26-300923 View SEC Doc Filr Page
4 2026-07-10 2026-07-08 4 0001193125-26-300922 View SEC Doc Filr Page
4 2026-07-10 2026-07-08 4 0001193125-26-300921 View SEC Doc Filr Page
4 2026-07-10 2026-07-08 4 0001193125-26-300920 View SEC Doc Filr Page
4 2026-07-10 2026-07-08 4 0001193125-26-300918 View SEC Doc Filr Page
4 2026-07-10 2026-07-08 4 0001193125-26-300916 View SEC Doc Filr Page
4 2026-07-10 2026-07-08 4 0001193125-26-300926 View SEC Doc Filr Page
4 2026-07-10 2026-07-08 4 0001193125-26-300924 View SEC Doc Filr Page
4 2026-07-10 2026-07-08 4 0001193125-26-300919 View SEC Doc Filr Page
4 2026-07-10 2026-07-08 4 0001193125-26-300914 View SEC Doc Filr Page
S-8 2026-07-09 — S-8 0001193125-26-299675 View SEC Doc Filr Page
8-K 2026-07-08 2026-07-08 8-K 0001193125-26-298525 View SEC Doc Filr Page
8-K 2026-07-08 2026-07-08 8-K 0001193125-26-298005 View SEC Doc Filr Page